[1]
G. Treglia, S. Taralli, and A. Giordano, “Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 28, no. 2, pp. 87–94, Dec. 2011, Accessed: Jan. 31, 2025. [Online]. Available: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/2538